Dimana Dimitrova
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dimana Dimitrova as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:36 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03922724 · Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell LymphomaNational Cancer Institute (NCI) · active not recruiting · Peripheral T-cell Lymphomas, Lymphoproliferative Disorders, Immune System Diseases · principal investigator
- Ph2NCT03663933 · Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or DysregulationNational Cancer Institute (NCI) · active not recruiting · Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders · principal investigator
- N/ANCT03111745 · Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010National Cancer Institute (NCI) · completed · Viral Infections · principal investigator
- Ph2NCT02579967 · Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary ImmunodeficienciesNational Cancer Institute (NCI) · recruiting · Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 16:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 16:36 UTC. The ranking covers the 200 most relevant of 20 PubMed records, and a shared surname and initials can bring in a namesake. All 20 on PubMed
- Preliminary study of two antiviral agents for hepatitis C genotype 1.N Engl J Med · 2012497 citationsRCR 14.9
- Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers.J Infect Dis · 201083 citationsRCR 2.4
- Anticipatory postural adjustments associated with arm movements during balancing on unstable support surface.Int J Psychophysiol · 199667 citationsRCR 3.5
- Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study.Clin Neuropharmacol · 200959 citationsRCR 2.2
- Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C.Hepatology · 201558 citationsRCR 2.0
- Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.Biol Blood Marrow Transplant · 202044 citationsRCR 2.2
- Pharmacokinetics of enrofloxacin in turkeys.Res Vet Sci · 200736 citationsRCR 1.8
- Group-based cardiac rehabilitation interventions. A challenge for physical and rehabilitation medicine physicians: a randomized controlled trial.Eur J Phys Rehabil Med · 202030 citationsRCR 2.2
- Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation.Blood Adv · 202529 citationsRCR 9.0
- Comparative pharmacokinetics of enrofloxacin, danofloxacin, and marbofloxacin after intravenous and oral administration in Japanese quail (Coturnix coturnix japonica).J Avian Med Surg · 201324 citationsRCR 1.6